HUP0303189A2 - Biszfoszfonátok vaginális bevitele - Google Patents

Biszfoszfonátok vaginális bevitele

Info

Publication number
HUP0303189A2
HUP0303189A2 HU0303189A HUP0303189A HUP0303189A2 HU P0303189 A2 HUP0303189 A2 HU P0303189A2 HU 0303189 A HU0303189 A HU 0303189A HU P0303189 A HUP0303189 A HU P0303189A HU P0303189 A2 HUP0303189 A2 HU P0303189A2
Authority
HU
Hungary
Prior art keywords
bisphosphonate
bisphosphonates
bone
disease
vagina
Prior art date
Application number
HU0303189A
Other languages
English (en)
Inventor
Donald C. Harrison
James H. Liu
Original Assignee
Umd, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umd, Inc. filed Critical Umd, Inc.
Publication of HUP0303189A2 publication Critical patent/HUP0303189A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya bifoszfonát alkalmazása humán nőbetegbencsontritkulás, Paget-betegség, csont- vagy csontrendszeri betegségvagy áttételes daganatos betegség kezelésére és megelőzésére szolgáló,transzvaginálisan alkalmazható biszfoszfonátot tartalmazó készítményvagy biszfoszfonátot tartalmazó készítményt tartalmazó eszközelőállítására, amellyel a bifoszfonát humán nőbetegben ahüvelynyálkahártyájához vagy hámjához juttatható. A biszfoszfonátokcélzott bevitelét a hüvelybe gyógyszert tartalmazó intravagináliseszközzel valósítják meg, amely transzvaginális bevitelre alkalmazhatóbiszfoszfonát készítményt tartalmaz. A csontritkulás és rokon csont-és csontrendszeri betegségek kezelésére, a csontleépülés, valamint acsonttömegvesztés és a csonterősség-csökkenés megelőzésérealkalmazható eljárást az jellemzi, hogy a biszfoszfonátokatintravaginálisan juttatják be a hüvelybe, és a biszfoszfonátokattranszvaginálisan juttatják be a keringési rendszerbe. Ó
HU0303189A 2000-07-27 2001-07-12 Biszfoszfonátok vaginális bevitele HUP0303189A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/626,025 US6572874B1 (en) 1998-05-15 2000-07-27 Vaginal delivery of bisphosphonates
PCT/US2001/022205 WO2002009631A1 (en) 2000-07-27 2001-07-12 Vaginal delivery of bisphosphonates

Publications (1)

Publication Number Publication Date
HUP0303189A2 true HUP0303189A2 (hu) 2003-12-29

Family

ID=24508641

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303189A HUP0303189A2 (hu) 2000-07-27 2001-07-12 Biszfoszfonátok vaginális bevitele

Country Status (16)

Country Link
US (1) US6572874B1 (hu)
EP (1) EP1311213A1 (hu)
JP (1) JP2004519420A (hu)
CN (1) CN1201749C (hu)
AU (2) AU2001278920B2 (hu)
BR (1) BR0113134A (hu)
CA (1) CA2416122A1 (hu)
CZ (1) CZ2003494A3 (hu)
HK (1) HK1054496A1 (hu)
HU (1) HUP0303189A2 (hu)
IL (2) IL154134A0 (hu)
MX (1) MXPA03000803A (hu)
NO (1) NO20030422L (hu)
NZ (1) NZ524069A (hu)
PL (1) PL365884A1 (hu)
WO (1) WO2002009631A1 (hu)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
US7744916B2 (en) * 1997-06-11 2010-06-29 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
US20040043071A1 (en) * 2002-06-21 2004-03-04 Pauletti Giovanni M. Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
HUP0400096A2 (hu) * 2001-05-02 2004-04-28 Novartis Ag. Biszfoszfonátok gyógyászati alkalmazása
PT1392325E (pt) * 2001-05-02 2006-10-31 Novartis Ag Metodo de administracao de bifosfonatos por inalacao no tratamento ou na prevencao da reabsorcao ossea e da osteoporose
WO2003003999A2 (en) 2001-07-02 2003-01-16 Elan Corporation, Plc. Delivery of a bioactive material
JP2005507874A (ja) * 2001-08-29 2005-03-24 ユーエムディー， インコーポレイテッド 癌治療のための化学療法剤及び膜流出システム阻害剤の経膣送達
BR0308901A (pt) * 2002-05-10 2005-01-04 Hoffmann La Roche ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose
NZ519112A (en) * 2002-05-22 2004-12-24 Interag Drug delivery device for administration of active agent to mammary gland cavity
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US8835014B2 (en) * 2002-10-22 2014-09-16 Allegiance Corporation Coating composition for skin-contacting surface of elastomeric articles and articles containing the same
WO2004096151A2 (en) * 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US8399013B2 (en) * 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
WO2005000858A2 (en) * 2003-06-27 2005-01-06 Akira Odani Bisphosphonate complexes
US20050113730A1 (en) * 2003-11-24 2005-05-26 Sca Hygiene Products Ab Absorbent Article Containing A Skin Care Product
JPWO2005077378A1 (ja) * 2004-02-18 2007-10-18 メルシャン株式会社 家畜哺乳動物の低カルシウム血症の予防、治療および／または処置方法
ITMI20040641A1 (it) * 2004-03-31 2004-06-30 Tb Technology S R L Composizioni bioadesive bifunzionali per implantologia orale
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US20050260272A1 (en) * 2004-05-05 2005-11-24 Alkermes Controlled Therapeutics, Inc. Method of forming microparticles that include a bisphosphonate and a polymer
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
US7919453B2 (en) 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7744556B2 (en) 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7708726B2 (en) 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
US20070016156A1 (en) * 2005-07-15 2007-01-18 The Procter & Gamble Company Absorbent tampon comprising a visually distinct withdrawal member
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CN101500583B (zh) * 2006-07-12 2012-05-23 控制治疗（苏格兰）有限公司 含克林霉素盐酸盐的药物递送聚合物
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
CN102215901B (zh) * 2008-11-07 2014-12-03 联合生物医学系统有限公司 用于治疗和/或预防疾病的装置和方法
CN101601662B (zh) * 2009-06-30 2011-08-31 胡传良 一种阿仑膦酸钠肠溶胶囊及其制备方法
EP3125964A4 (en) * 2014-04-01 2018-02-28 Poly-Med Inc. Contraceptive and related device
MX2023007586A (es) 2021-01-14 2023-07-07 Herphoric Inc Un sistema de suministro para un componente farmaceutico, holistico o medicinal.
US20230263724A1 (en) * 2022-02-22 2023-08-24 Celanese Eva Performance Polymers Llc Intravaginal Ring Device for the Delivery of Aromatase Inhibitor

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852155A (en) 1971-09-02 1974-12-03 R Moore Cryopreservation of equine cell cultures
US3884233A (en) 1973-09-04 1975-05-20 Betty Louise Summey Tampon and suppository combination
US3902493A (en) 1974-05-13 1975-09-02 Procter & Gamble Medicated catamenial tampon
US4073743A (en) 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4016270A (en) 1975-10-31 1977-04-05 Alza Corporation Method for treating dysmenorrhea with a uterine therapeutic system
US4250166A (en) 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
US4309997A (en) 1978-06-09 1982-01-12 Donald Jack W Contraceptive and/or antivenereal disease tampon
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4318405A (en) 1980-07-24 1982-03-09 Sneider Vincent R Tampon and drug delivery device
US4405323A (en) 1981-09-08 1983-09-20 Sidney Auerbach Sanitary napkin
US4698359A (en) * 1982-08-24 1987-10-06 Cilag, Ag Medicated suppository
US4863725A (en) 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4560549A (en) 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US4615697A (en) 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4983392A (en) 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
JPS6160620A (ja) 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3584523D1 (de) 1985-10-31 1991-11-28 Kv Pharm Co System zum freigeben von stoffen in der vagina.
EP0283085B1 (en) 1987-03-17 1992-11-11 Akzo N.V. Adjuvant mixture
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
CA1341245C (en) 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
IT1230157B (it) 1989-06-16 1991-10-14 Lisapharma Spa Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
DE3928677C2 (de) 1989-08-30 1998-05-14 Kimberly Clark Gmbh Tampon für medizinische oder hygienische Zwecke sowie Verfahren zu seiner Herstellung
FR2665357B1 (fr) 1990-07-31 1995-03-31 Aiache Jean Marc Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
US5275820A (en) 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
JPH0767716B2 (ja) 1991-01-14 1995-07-26 新日鐵化学株式会社 熱可塑性樹脂成形品の射出成形法及び射出成形用金型
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
US5273521A (en) 1992-08-26 1993-12-28 Peiler Frances K Tampon applicator for delivery of a medicament
EP0665733B1 (en) 1992-10-21 2003-05-07 Gynetech Laboratories, Inc. Vaginal sponge delivery system
US5330761A (en) 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
GB9522403D0 (en) 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US7592255B2 (en) 2004-12-22 2009-09-22 Hewlett-Packard Development Company, L.P. Fabricating arrays of metallic nanostructures

Also Published As

Publication number Publication date
PL365884A1 (en) 2005-01-10
CN1201749C (zh) 2005-05-18
IL154134A (en) 2008-11-26
CN1461207A (zh) 2003-12-10
BR0113134A (pt) 2004-06-22
US6572874B1 (en) 2003-06-03
NO20030422L (no) 2003-03-11
CZ2003494A3 (cs) 2003-08-13
IL154134A0 (en) 2003-07-31
JP2004519420A (ja) 2004-07-02
NZ524069A (en) 2007-02-23
EP1311213A1 (en) 2003-05-21
AU7892001A (en) 2002-02-13
HK1054496A1 (zh) 2003-12-05
AU2001278920B2 (en) 2006-03-02
CA2416122A1 (en) 2002-02-07
MXPA03000803A (es) 2003-06-04
NO20030422D0 (no) 2003-01-27
WO2002009631A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
HUP0303189A2 (hu) Biszfoszfonátok vaginális bevitele
Farah et al. Tongue piercing: case report and review of current practice
JP2003527404A5 (hu)
CN100455323C (zh) 一种治疗骨质增生、腰椎间盘突出症的膏药
Roberts Bilateral hyperplastic callus formation in osteogenesis imperfecta
HUP9802077A2 (hu) Alendronát alkalmazása csigolyatörések kockázatát csökkentő gyógyszerkészítmény előállítására
CN1965912B (zh) 中药远志作为唯一活性成分在制备体外杀精子药物中的应用及其制备药物的方法
Stanko et al. Squamous cell carcinoma and piercing of the tongue–A case report
Mattoo Tongue Crenation (Scalloped Tongue)–Case Report
Karapinar et al. A case of myositis ossificans as a complication of tetanus treated by surgical excision
Eshtayevna et al. Clinical Basis For Opening And Draining Mouthpiece Flegmonas
AU2005251573A1 (en) Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms
RU2138229C1 (ru) Пессарий в.ф.гробеля
Hunter et al. Spinal epidural abscess in pregnancy
de la Osa Gonzalez Clinical response of abnormal endometrial growth to hormonal treatment
Goldberg et al. Ameloblastoma: review of the literature and report of case
Webster Nitrous Oxid Gas Analgesia in Obstetrics
T O'Leary et al. Vaccination Practices Among Obstetrician/Gynecologists for Non-pregnant Patients
CN1137695C (zh) 一种治疗偏瘫高血压的药贴
JP3037318U (ja) 靴の中敷
RU2079294C1 (ru) Способ купирования болевого синдрома при внутриматочной контрацепции
Farina et al. Gorlin-Goltz Syndrome: Report of Two Cases From the Same Family
Vinogradova et al. The optimization of osteoreparative process after vestibuloplasty
RU21345U1 (ru) Виброаспиратор цервикальный (вац)
Seaman The Case of the Infected Lung

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees